The rate of drug-related complications in the group of patients who were treated not following ACR 2011 was 3 times higher than in the group who were treated following ACR 2011.
Biến chứng do thuốc ở nhóm điều trị không theo ACR 2011 cao gấp 3 lần nhóm điều trị theo ACR 2011.